Wealth Advisory Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Wealth Advisory Solutions's BMY Position: Q1 2026 in Review

Wealth Advisory Solutions increased its Bristol-Myers Squibb (BMY) stake by 40% in Q1 2026, buying an estimated $181K and bringing the position to 10,953 shares worth $664K. The position accounts for 0.15% of the portfolio, ranked #83.

Wealth Advisory Solutions first reported a position in BMY in Q4 2019 and has held it in 14 quarters since. The position peaked at $790K in Q1 2021. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

• Wealth Advisory Solutions held 10,953 shares of Bristol-Myers Squibb worth $664K as of Q1 2026.
• Wealth Advisory Solutions bought 3,110 Bristol-Myers Squibb shares in Q1 2026, an estimated $181K.
• Bristol-Myers Squibb made up 0.15% of Wealth Advisory Solutions's portfolio in Q1 2026, its #83 holding.
• Wealth Advisory Solutions first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 14 quarters since.
• Wealth Advisory Solutions's Bristol-Myers Squibb position peaked at $790K in Q1 2021.
• 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Wealth Advisory Solutions's 13F filing for Q1 2026, filed 22 Apr 2026.